Status:
TERMINATED
Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Anesthetics, Local
Esophagogastroduodenoscopy
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper GI endoscopy
Eligibility Criteria
Inclusion
- Patients referred to and found fit for upper GI endoscopy in an out patient setting
- Between 18 and 75 years old
- Speaks and understands Danish
Exclusion
- Patients admitted for upper GI endoscopy in an in-patient setting
- Patients with dementia and/or other cognitive dysfunction disorders
- Patients primarily complaining of dysphagia
- Patients allergic to lidocaine
- Patients with suspected retention
- Patients who will undergo upper GI endoscopy with nurse-assisted propofol sedation
- Patients who will undergo upper GI endoscopy with assistance of anesthesia-personnel
Key Trial Info
Start Date :
March 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT04725695
Start Date
March 29 2022
End Date
October 30 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endoscopy, Digestive Disease Center, Bispebjerg Hospital
Copenhagen, Denmark, 2400